- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01782547
Telehealth Intervention for Youth With T1DM
August 12, 2016 updated by: Erinn T. Rhodes, Boston Children's Hospital
Telehealth Intervention for Youth With Type 1 Diabetes
Hospitalization of youth with established diabetes is both costly and frequently preventable.
Poor glycemic control is a risk factor for hospitalization and is also associated with adolescent age and lower socioeconomic status.
This is a randomized, controlled trial for high-risk adolescent youth with T1DM and suboptimal glycemic control with an intervention arm and usual care control arm matched for frequency of contacts.
There will be 110 subjects with T1DM and HbA1c>8%, aged 13 to 17 years, recruited from the Diabetes Program at Boston Children's Hospital and followed for 6 months.
The intervention will be implemented by a diabetes nurse educator and social worker, who will each have monthly contact with the adolescent and a parent/guardian through a telehealth (videoconference) visit.
Care will be guided by a diabetes action plan.
Telehealth interventions have been utilized successfully in both adults and youth with diabetes.
They facilitate frequent contact with the care team allowing barriers to adherence to be addressed, education to be reinforced, care plans to be updated, and diabetes-specific family support to be provided.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 13 to 17 years
- Type 1 diabetes for ≥1 year
- HbA1c>8%
- Able to speak and read English (Child)
- Able to speak and read English (Parent)
- Parent agrees to participate
- Parent and child each have email addresses
Exclusion Criteria:
- Plan to transition diabetes care to a center other than Boston Children's Hospital
- No visit to Boston Children's Hospital Diabetes Program in year prior to recruitment
- Current participation in another diabetes-related study with an intervention
- Living with or related to another study participant
- Significant psychopathology or medical illness that would limit the subject's ability to provide assent and/or participate in the study procedures as determined by the PI.
- No internet access
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telehealth Intervention
Telehealth intervention - 6 months
|
Monthly videoconference with diabetes nurse educator; Monthly videoconference with social worker; Diabetes action plan;
|
Active Comparator: Usual care
Usual care control with comparable frequency of contact
|
Standard diabetes care- typically a visit with a diabetes health care provider every 3 months and referrals to a dietitian or mental health specialist as deemed appropriate; Study participation reminder cards twice per month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Hemoglobin A1c
Time Frame: baseline and 6 months
|
Change in hemoglobin A1c over 6 months
|
baseline and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
% patients meeting ADA HbA1c target
Time Frame: At 6 months
|
proportion of patients meeting the American Diabetes Association target for optimal glycemic control in this age group, which is <7.5%
|
At 6 months
|
Diabetes-related adverse events
Time Frame: Up to 6 months
|
number of diabetes-related hospitalizations, ED visits, and episodes of severe hypoglycemia
|
Up to 6 months
|
Change in Diabetes self-efficacy
Time Frame: Baseline and 6 months
|
change over 6 months assessed by questionnaire
|
Baseline and 6 months
|
Change in Adherence to diabetes self-management
Time Frame: Baseline and 6 months
|
change over 6 months assessed by questionnaire
|
Baseline and 6 months
|
Change in competence with diabetes skills
Time Frame: Baseline and 6 months
|
change over 6 months assessed by questionnaire
|
Baseline and 6 months
|
Change in Health related quality of life
Time Frame: Baseline and 6 months
|
change over 6 months assessed by questionnaire
|
Baseline and 6 months
|
Change in Diabetes Knowledge
Time Frame: Baseline and 6 months
|
Change over 6 months assessed by questionnaire
|
Baseline and 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Direct medical costs
Time Frame: Up to 6 months
|
Direct medical costs include planned intervention costs and medical costs that are expected to change as a result of the intervention.
|
Up to 6 months
|
Change in diabetes-related family conflict
Time Frame: Baseline and 6 months
|
assessed by questionnaire
|
Baseline and 6 months
|
Change in family responsibility for diabetes tasks
Time Frame: Baseline and 6 months
|
assessed by questionnaire
|
Baseline and 6 months
|
Telehealth intervention satisfaction
Time Frame: At 6 months
|
satisfaction, engagement, visit characteristics
|
At 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erinn T Rhodes, MD, MPH, Boston Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
January 28, 2013
First Submitted That Met QC Criteria
January 31, 2013
First Posted (Estimate)
February 4, 2013
Study Record Updates
Last Update Posted (Estimate)
August 15, 2016
Last Update Submitted That Met QC Criteria
August 12, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P00006175
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Hoffmann-La RocheRoche DiagnosticsCompletedDiabetes Mellitus Type 2, Diabetes Mellitus Type 1Germany
Clinical Trials on Telehealth Intervention
-
VA Boston Healthcare SystemSamueli Institute for Information BiologyCompletedPost Traumatic Stress DisordersUnited States
-
Vanderbilt University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)RecruitingChronic Low-back Pain | Postsurgical Pain | Lumbar Spine SurgeryUnited States
-
Duke UniversityNational Institute of Mental Health (NIMH)Recruiting
-
University of California, Los AngelesPatient-Centered Outcomes Research InstituteCompletedDepression | Anxiety | Developmental Delay | Autism | Behavioral Problems | Adhd | Developmental, Behavioral and Mental HealthUnited States
-
Columbia UniversityNot yet recruitingAdherence to In-Office Glaucoma Evaluation Appointment
-
Duke UniversityCompletedHypertension | Diabetes | Diabetic Kidney DiseaseUnited States
-
Georgetown UniversityNot yet recruitingCancer | Periodontal Diseases | Oral Mucositis
-
University of British ColumbiaVancouver Coastal Health Research InstituteNot yet recruitingQuality of Life | Medication Adherence | Asthma ExacerbationCanada
-
South Florida Veterans Affairs Foundation for Research...UnknownDiabetes | Pre-diabetesUnited States
-
Indiana UniversityCompletedChildhood ObesityUnited States